Lin Li

发表

GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease

Christian Hölscher, Chong Gao, C. Hölscher, 2012, Reviews in the neurosciences.

The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson's Disease.

C. Hölscher, M. Rosenkilde, Lin Li, 2020, Journal of Parkinson's disease.

Geniposide protection against Aβ1-42 toxicity correlates with mTOR inhibition and enhancement of autophagy.

Yan-fang Chang, Xiao-hui Wang, Lin Li, 2021, Journal of integrative neuroscience.

Incretin-based therapy for type 2 diabetes mellitus is promising for treating neurodegenerative diseases

C. Hölscher, Lin Li, Yanwei Li, 2016, Reviews in the neurosciences.

The Molecular Mechanism of Glucagon-Like Peptide-1 Therapy in Alzheimer’s Disease, Based on a Mechanistic Target of Rapamycin Pathway

Lin Li, 2017, CNS Drugs.

Is Glucagon-like peptide-1, an agent treating diabetes, a new hope for Alzheimer’s disease?

Lin Li, 2007, Neuroscience Bulletin.

A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson’s disease by reducing chronic inflammation in the brain

C. Hölscher, Lin Li, Dong-fang Li, 2016, Neuroreport.

Neuroprotective effects of an oxyntomodulin analogue in the MPTP mouse model of Parkinson's disease.

C. Hölscher, J. Jalewa, Lin Li, 2015, European journal of pharmacology.

A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson′s disease by increasing expression of BNDF

C. Hölscher, Cao Lijun, Lin Li, 2016, Brain Research.

Intranasal administration of Exendin-4 antagonizes Aβ31–35-induced disruption of circadian rhythm and impairment of learning and memory

Lin Li, Xiao-hui Wang, Yunyun Xu, 2016, Aging Clinical and Experimental Research.

Metabolic profiling of the effects of ginsenoside Re in an Alzheimer’s disease mouse model

Y. Liu, Wei Li, Lin Li, 2018, Behavioural Brain Research.

Neuroprotective effects of geniposide in the MPTP mouse model of Parkinson's disease.

C. Hölscher, Yanfang Zhang, Lin Li, 2015, European journal of pharmacology.

Neuroprotective effect of geniposide on Parkinson's disease model mice

Lin Li, Yan-fang Zhang, Yimei Chen, 2015 .

Neuroprotective effects of lixisenatide and liraglutide in the MPTP mouse model of Parkinson's disease.

C. Hölscher, J. Jalewa, Lin Li, 2015 .

Semaglutide-mediated protection against Aβ correlated with enhancement of autophagy and inhibition of apotosis

Yan-fang Chang, Lin Li, Dong-xing Liu, 2020, Journal of Clinical Neuroscience.

Quantitative analysis of iron concentration and expression of ferroportin 1 in the cortex and hippocampus of rats induced by cerebral ischemia

Lin Li, C. Holscher, Yan-wei Li, 2009, Journal of Clinical Neuroscience.

Hepcidin Treatment Modulates the Expression of Divalent Metal Transporter-1, Ceruloplasmin, and Ferroportin-1 in the Rat Cerebral Cortex and Hippocampus

Zhi‐Feng Zhang, Lin Li, C. Holscher, 2011, Biological Trace Element Research.

Therapeutic Potential of Genipin in Central Neurodegenerative Diseases

C. Hölscher, Lin Li, Yanwei Li, 2016, CNS Drugs.

Geniposide prevents rotenone-induced apoptosis in primary cultured neurons

Juan Zhao, Lin Li, Guang-lai Li, 2015, Neural regeneration research.

Neuroprotective effects of the novel GLP-1 long acting analogue semaglutide in the MPTP Parkinson's disease mouse model

C. Hölscher, Lin Li, Lingyu Zhang, 2018, Neuropeptides.

D‐Ala2‐GIP‐glu‐PAL is neuroprotective in a chronic Parkinson's disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation

C. Hölscher, Lin Li, Yanwei Li, 2017, European journal of pharmacology.

Common pathological processes in Alzheimer disease and type 2 diabetes: A review

Christian Hölscher, C. Hölscher, Lin Li, 2007, Brain Research Reviews.

Geniposide-mediated protection against amyloid deposition and behavioral impairment correlates with downregulation of mTOR signaling and enhanced autophagy in a mouse model of Alzheimer's disease

Yueze Liu, Lin Li, Di Zhang, 2019, Aging.

Neuroprotective effects of geniposide on Alzheimer’s disease pathology

C. Hölscher, Lin Li, Guang-lai Li, 2015, Reviews in the neurosciences.

Geniposide Ameliorates Learning Memory Deficits, Reduces Tau Phosphorylation and Decreases Apoptosis via GSK3β Pathway in Streptozotocin‐Induced Alzheimer Rat Model

Yueze Liu, C. Gao, Lin Li, 2014, Brain pathology.

New animal models of Alzheimer’s disease that display insulin desensitization in the brain

C. Hölscher, Yueze Liu, C. Gao, 2013, Reviews in the neurosciences.

Neuroprotective effects of a GIP analogue in the MPTP Parkinson's disease mouse model

C. Hölscher, Lin Li, Yanwei Li, 2016, Neuropharmacology.

Semaglutide is Neuroprotective and Reduces α-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson's Disease.

C. Hölscher, Lin Li, Lingyu Zhang, 2019, Journal of Parkinson's disease.

New roles for insulin-like hormones in neuronal signalling and protection: New hopes for novel treatments of Alzheimer’s disease?

Christian Hölscher, C. Hölscher, Lin Li, 2010, Neurobiology of Aging.

Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model

C. Hölscher, Lin Li, Lingyu Zhang, 2021, Neural regeneration research.

mTOR-Autophagy: A Key for Geniposide Protection in APP/PS1 Transgenic Mice

Xiao-hui Wang, Yueze Liu, Lin Li, 2020 .

A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model

C. Hölscher, Lin Li, Zhihua Zhang, 2017, Behavioural Brain Research.

Geniposide effectively reverses cognitive impairment and inhibits pathological cerebral damage by regulating the mTOR Signal pathway in APP∕PS1 mice

Yueze Liu, Lin Li, Di Zhang, 2020, Neuroscience Letters.

DA5-CH and Semaglutide Protect against Neurodegeneration and Reduce α-Synuclein Levels in the 6-OHDA Parkinson's Disease Rat Model

C. Hölscher, Lin Li, Lin Li, 2022, Parkinson's disease.

(Val⁸) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains.

Zhi‐Feng Zhang, C. Gao, Lin Li, 2012, European journal of pharmacology.

D‐Ser2‐oxyntomodulin ameliorated Aβ31‐35‐induced circadian rhythm disorder in mice

C. Hölscher, Lin Li, Yuan Yuan, 2019, CNS neuroscience & therapeutics.

Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease

Christian Hölscher, C. Hölscher, Lin Li, 2018, Brain Research.

Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease

C. Hölscher, M. Sharma, J. Jalewa, 2015, Neuroscience.

Neuroprotective effects of (Val8)GLP-1-Glu-PAL in the MPTP Parkinson’s disease mouse model

C. Hölscher, Yanfang Zhang, Lin Li, 2015, Behavioural Brain Research.

DA-JC1 improves learning and memory by antagonizing Aβ31–35-induced circadian rhythm disorder

C. Hölscher, Lin Li, Rui Zhang, 2019, Molecular Brain.

Val8-glucagon-like peptide-1 protects against Aβ1–40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats

C. Hölscher, Lin Li, L. Li, 2010, Neuroscience.

Neuroprotective role of (Val8)GLP-1-Glu-PAL in an in vitro model of Parkinson's disease

Juan Zhao, Lin Li, C. Holscher, 2016, Neural regeneration research.

Neuroprotective effects of a GIP analogue in the MPTP Parkinson's disease mouse model

C. Hölscher, Lin Li, Yanwei Li, 2016, Neuropharmacology.